{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T09:06:50Z","timestamp":1793783210810,"version":"4.6.1"},"reference-count":136,"publisher":"Springer Science and Business Media LLC","issue":"19","license":[{"start":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T00:00:00Z","timestamp":1724716800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T00:00:00Z","timestamp":1724716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000057","name":"HHS | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R01GM33289"],"award-info":[{"award-number":["R01GM33289"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"HHS | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["RM1GM131981-01"],"award-info":[{"award-number":["RM1GM131981-01"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"HHS | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["RM1GM131981-01"],"award-info":[{"award-number":["RM1GM131981-01"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-21-CE11-0022-01"],"award-info":[{"award-number":["ANR-21-CE11-0022-01"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["22POST908934"],"award-info":[{"award-number":["22POST908934"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO J"],"DOI":"10.1038\/s44318-024-00199-x","type":"journal-article","created":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T17:02:21Z","timestamp":1724778141000},"page":"4139-4155","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Reassessing the unifying hypothesis for hypercontractility caused by myosin mutations in hypertrophic cardiomyopathy"],"prefix":"10.1038","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4324-4254","authenticated-orcid":false,"given":"James A","family":"Spudich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6958-3756","authenticated-orcid":false,"given":"Neha","family":"Nandwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6102-2025","authenticated-orcid":false,"given":"Julien","family":"Robert-Paganin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8566-0336","authenticated-orcid":false,"given":"Anne","family":"Houdusse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0971-5331","authenticated-orcid":false,"given":"Kathleen M","family":"Ruppel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,27]]},"reference":[{"key":"199_CR1","doi-asserted-by":"publisher","first-page":"9204","DOI":"10.1074\/jbc.M610899200","volume":"282","author":"A Ababou","year":"2007","unstructured":"Ababou A, Gautel M, Pfuhl M (2007) Dissecting the N-terminal myosin binding site of human cardiac myosin-binding protein C. J Biol Chem 282:9204\u20139215","journal-title":"J Biol Chem"},{"key":"199_CR2","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.jmb.2008.09.065","volume":"384","author":"A Ababou","year":"2008","unstructured":"Ababou A, Rostkova E, Mistry S, Le Masurier C, Gautel M, Pfuhl M (2008) Myosin binding protein C positioned to play a key role in regulation of muscle contraction: structure and interactions of domain C1. J Mol Biol 384:615\u2013630","journal-title":"J Mol Biol"},{"key":"199_CR3","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1016\/j.celrep.2016.11.040","volume":"17","author":"AS Adhikari","year":"2016","unstructured":"Adhikari AS, Kooiker KB, Sarkar SS, Liu C, Bernstein D, Spudich JA, Ruppel KM (2016) Early-onset hypertrophic cardiomyopathy mutations significantly increase the velocity, force, and actin-activated ATPase activity of human \u03b2-cardiac myosin. Cell Rep 17:2857\u20132864","journal-title":"Cell Rep"},{"key":"199_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10555-9","volume":"10","author":"AS Adhikari","year":"2019","unstructured":"Adhikari AS, Trivedi DV, Sarkar SS, Song D, Kooiker KB, Bernstein D, Spudich JA, Ruppel KM (2019) \u03b2-Cardiac myosin hypertrophic cardiomyopathy mutations release sequestered heads and increase enzymatic activity. Nat Commun 10:2685","journal-title":"Nat Commun"},{"key":"199_CR5","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1039\/C5MB00163C","volume":"11","author":"L Alamo","year":"2015","unstructured":"Alamo L, Li X, (Edward), Espinoza-Fonseca LM, Pinto A, Thomas DD, Lehman W, Padr\u00f3n R (2015) Tarantula myosin free head regulatory light chain phosphorylation stiffens N-terminal extension, releasing it and blocking its docking back. Mol Biosyst 11:2180\u20132189","journal-title":"Mol Biosyst"},{"key":"199_CR6","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1007\/s12551-017-0292-4","volume":"10","author":"L Alamo","year":"2018","unstructured":"Alamo L, Pinto A, Sulbar\u00e1n G, Mav\u00e1rez J, Padr\u00f3n R (2018) Lessons from a tarantula: new insights into myosin interacting-heads motif evolution and its implications on disease. Biophys Rev 10:1465\u20131477","journal-title":"Biophys Rev"},{"key":"199_CR7","doi-asserted-by":"publisher","first-page":"e24634","DOI":"10.7554\/eLife.24634","volume":"6","author":"L Alamo","year":"2017","unstructured":"Alamo L, Ware JS, Pinto A, Gillilan RE, Seidman JG, Seidman CE, Padron R (2017) Effects of myosin variants on interacting-heads motif explain distinct hypertrophic and dilated cardiomyopathy phenotypes. Elife 6:e24634","journal-title":"Elife"},{"key":"199_CR8","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.jmb.2008.10.013","volume":"384","author":"L Alamo","year":"2008","unstructured":"Alamo L, Wriggers W, Pinto A, B\u00e1rtoli F, Salazar L, Zhao FQ, Craig R, Padr\u00f3n R (2008) Three-dimensional reconstruction of tarantula myosin filaments suggests how phosphorylation may regulate myosin activity. J Mol Biol 384:780\u2013797","journal-title":"J Mol Biol"},{"key":"199_CR9","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/gim.2014.205","volume":"17","author":"AA Alfares","year":"2015","unstructured":"Alfares AA, Kelly MA, McDermott G, Funke BH, Lebo MS, Baxter SB, Shen J, McLaughlin HM, Clark EH, Babb LJ et al (2015) Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivity. Genet Med 17:880\u2013888","journal-title":"Genet Med"},{"key":"199_CR10","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1073\/pnas.1212708110","volume":"110","author":"HA Al-Khayat","year":"2013","unstructured":"Al-Khayat HA, Kensler RW, Squire JM, Marston SB, Morris EP (2013) Atomic model of the human cardiac muscle myosin filament. Proc Natl Acad Sci USA 110:318\u2013323","journal-title":"Proc Natl Acad Sci USA"},{"key":"199_CR11","doi-asserted-by":"publisher","first-page":"E8143","DOI":"10.1073\/pnas.1809540115","volume":"115","author":"RL Anderson","year":"2018","unstructured":"Anderson RL, Trivedi DV, Sarkar SS, Henze M, Ma W, Gong H, Rogers CS, Gorham JM, Wong FL, Morck MM et al (2018) Deciphering the super relaxed state of human beta-cardiac myosin and the mode of action of mavacamten from myosin molecules to muscle fibers. Proc Natl Acad Sci USA 115:E8143\u2013E8152","journal-title":"Proc Natl Acad Sci USA"},{"key":"199_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47587-9","volume":"15","author":"D Auguin","year":"2024","unstructured":"Auguin D, Robert-Paganin J, R\u00e9ty S, Kikuti C, David A, Theumer G, Schmidt AW, Kn\u00f6lker H-J, Houdusse A (2024) Omecamtiv mecarbil and Mavacamten target the same myosin pocket despite opposite effects in heart contraction. Nat Commun 15:4885","journal-title":"Nat Commun"},{"key":"199_CR13","doi-asserted-by":"publisher","first-page":"17713","DOI":"10.1073\/pnas.0606741103","volume":"103","author":"W Blankenfeldt","year":"2006","unstructured":"Blankenfeldt W, Thom\u00e4 NH, Wray JS, Gautel M, Schlichting I (2006) Crystal structures of human cardiac \u03b2-myosin II S2-\u0394 provide insight into the functional role of the S2 subfragment. Proc Natl Acad Sci USA 103:17713\u201317717","journal-title":"Proc Natl Acad Sci USA"},{"key":"199_CR14","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1146\/annurev-physiol-042222-022728","volume":"86","author":"E Brunello","year":"2024","unstructured":"Brunello E, Fusi L (2024) Regulating striated muscle contraction: through thick and thin. Annu Rev Physiol 86:255\u2013275","journal-title":"Annu Rev Physiol"},{"key":"199_CR15","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.jmb.2007.07.014","volume":"372","author":"SA Burgess","year":"2007","unstructured":"Burgess SA, Yu S, Walker ML, Hawkins RJ, Chalovich JM, Knight PJ (2007) Structures of smooth muscle myosin and heavy meromyosin in the folded, shutdown state. J Mol Biol 372:1165\u20131178","journal-title":"J Mol Biol"},{"key":"199_CR16","doi-asserted-by":"publisher","first-page":"e172599","DOI":"10.1172\/JCI172599","volume":"134","author":"M Buvoli","year":"2024","unstructured":"Buvoli M, Wilson GCK, Buvoli A, Gugel JF, Hau A, B\u00f6nnemann CG, Paradas C, Ryba DM, Woulfe KC, Walker LA et al (2024) A Laing distal myopathy\u2013associated proline substitution in the \u03b2-myosin rod perturbs myosin cross-bridging activity. J Clin Invest 134:e172599","journal-title":"J Clin Invest"},{"key":"199_CR17","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1161\/CIRCIMAGING.114.002411","volume":"7","author":"G Captur","year":"2014","unstructured":"Captur G, Lopes LR, Mohun TJ, Patel V, Li C, Bassett P, Finocchiaro G, Ferreira VM, Esteban MT, Muthurangu V et al (2014) Prediction of sarcomere mutations in subclinical hypertrophic cardiomyopathy. Circ Cardiovasc Imaging 7:863\u2013871","journal-title":"Circ Cardiovasc Imaging"},{"key":"199_CR18","doi-asserted-by":"publisher","first-page":"e172322","DOI":"10.1172\/jci.insight.172322","volume":"8","author":"G Carrington","year":"2023","unstructured":"Carrington G, Hau A, Kosta S, Dugdale HF, Muntoni F, D\u2019Amico A, Van den Bergh P, Romero NB, Malfatti E, Vilchez JJ et al (2023) Human skeletal myopathy myosin mutations disrupt myosin head sequestration. JCI Insight 8:e172322","journal-title":"JCI Insight"},{"key":"199_CR19","doi-asserted-by":"publisher","first-page":"e2311883121","DOI":"10.1073\/pnas.2311883121","volume":"121","author":"L Chen","year":"2024","unstructured":"Chen L, Liu J, Rastegarpouyani H, Janssen PML, Pinto JR, Taylor KA (2024) Structure of mavacamten-free human cardiac thick filaments within the sarcomere by cryoelectron tomography. Proc Natl Acad Sci USA 121:e2311883121","journal-title":"Proc Natl Acad Sci USA"},{"key":"199_CR20","doi-asserted-by":"publisher","first-page":"101157","DOI":"10.1016\/j.jbc.2021.101157","volume":"297","author":"S Chu","year":"2021","unstructured":"Chu S, Muretta JM, Thomas DD (2021) Direct detection of the myosin super-relaxed state and interacting-heads motif in solution. J Biol Chem 297:101157","journal-title":"J Biol Chem"},{"key":"199_CR21","doi-asserted-by":"publisher","first-page":"14142","DOI":"10.1021\/acs.jmedchem.1c01290","volume":"64","author":"C Chuang","year":"2021","unstructured":"Chuang C, Collibee S, Ashcraft L, Wang W, Vander Wal M, Wang X, Hwee DT, Wu Y, Wang J, Chin ER et al (2021) Discovery of aficamten (CK-274), a next-generation cardiac myosin inhibitor for the treatment of hypertrophic cardiomyopathy. J Med Chem 64:14142\u201314152","journal-title":"J Med Chem"},{"key":"199_CR22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s12551-011-0044-9","volume":"3","author":"R Cooke","year":"2011","unstructured":"Cooke R (2011) The role of the myosin ATPase activity in adaptive thermogenesis by skeletal muscle. Biophys Rev 3:33\u201345","journal-title":"Biophys Rev"},{"key":"199_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1085\/jgp.202113012","volume":"154","author":"R Craig","year":"2022","unstructured":"Craig R, Padr\u00f3n R (2022) Structural basis of the super-and hyper-relaxed states of myosin II. J Gen Physiol 154:1\u201314","journal-title":"J Gen Physiol"},{"key":"199_CR24","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1083\/jcb.105.3.1319","volume":"105","author":"R Craig","year":"1987","unstructured":"Craig R, Padr\u00f3n R, Kendrick-Jones J (1987) Structural changes accompanying phosphorylation of tarantula muscle myosin filaments. J Cell Biol 105:1319\u20131327","journal-title":"J Cell Biol"},{"key":"199_CR25","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1074\/jbc.270.5.2171","volume":"270","author":"CR Cremo","year":"1995","unstructured":"Cremo CR, Sellers JR, Facemyer KC (1995) Two heads are required for phosphorylation-dependent regulation of smooth muscle myosin. J Biol Chem 270:2171\u20132175","journal-title":"J Biol Chem"},{"key":"199_CR26","doi-asserted-by":"publisher","first-page":"e148557","DOI":"10.1172\/JCI148557","volume":"132","author":"SM Day","year":"2022","unstructured":"Day SM, Tardiff JC, Ostap EM (2022) Myosin modulators: emerging approaches for the treatment of cardiomyopathies and heart failure. J Clin Invest 132:e148557","journal-title":"J Clin Invest"},{"key":"199_CR27","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1007\/s00018-012-0927-3","volume":"69","author":"JC Deacon","year":"2012","unstructured":"Deacon JC, Bloemink MJ, Rezavandi H, Geeves MA, Leinwand LA (2012) Identification of functional differences between recombinant human \u03b1 and \u03b2 cardiac myosin motors. Cell Mol Life Sci 69:2261\u201377","journal-title":"Cell Mol Life Sci"},{"key":"199_CR28","doi-asserted-by":"publisher","first-page":"e202313522","DOI":"10.1085\/jgp.202313522","volume":"156","author":"S Duno-Miranda","year":"2024","unstructured":"Duno-Miranda S, Nelson SR, Rasicci DV, Bodt SML, Cirilo Jr JA, Vang D, Sivaramakrishnan S, Yengo CM, Warshaw DM (2024) Tail length and E525K dilated cardiomyopathy mutant alter human \u03b2-cardiac myosin super-relaxed state. J Gen Physiol 156:e202313522","journal-title":"J Gen Physiol"},{"key":"199_CR29","doi-asserted-by":"publisher","first-page":"403a","DOI":"10.1016\/j.bpj.2023.11.2468","volume":"123","author":"D Dutta","year":"2024","unstructured":"Dutta D, Kim Y, Seidman JG, Craig R, Seidman CE, Padron R (2024) Pathogenic cardiac thick filament variants: a structural perspective. Biophys J 123:403a","journal-title":"Biophys J"},{"key":"199_CR30","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/s41586-023-06691-4","volume":"623","author":"D Dutta","year":"2023","unstructured":"Dutta D, Nguyen V, Campbell KS, Padr\u00f3n R, Craig R (2023) Cryo-EM structure of the human cardiac myosin filament. Nature 623:853\u2013862","journal-title":"Nature"},{"key":"199_CR31","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1039\/C5MB00162E","volume":"11","author":"LM Espinoza-Fonseca","year":"2015","unstructured":"Espinoza-Fonseca LM, Alamo L, Pinto A, Thomas DD, Padr\u00f3n R (2015) Sequential myosin phosphorylation activates tarantula thick filament via a disorder\u2013order transition. Mol Biosyst 11:2167\u20132179","journal-title":"Mol Biosyst"},{"key":"199_CR32","doi-asserted-by":"publisher","first-page":"167295","DOI":"10.1016\/j.jmb.2021.167295","volume":"433","author":"SK Gollapudi","year":"2021","unstructured":"Gollapudi SK, Ma W, Chakravarthy S, Combs AC, Sa N, Langer S, Irving TC, Nag S (2021) Two classes of myosin inhibitors, para-nitroblebbistatin and mavacamten, stabilize \u03b2-cardiac myosin in different structural and functional states. J Mol Biol 433:167295","journal-title":"J Mol Biol"},{"key":"199_CR33","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1126\/science.aad3456","volume":"351","author":"EM Green","year":"2016","unstructured":"Green EM, Wakimoto H, Anderson RL, Evanchik MJ, Gorham JM, Harrison BC, Henze M, Kawas R, Oslob JD, Rodriguez HM et al (2016) A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice. Science 351:617\u2013621","journal-title":"Science"},{"key":"199_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38698-w","volume":"14","author":"A Grinzato","year":"2023","unstructured":"Grinzato A, Auguin D, Kikuti C, Nandwani N, Moussaoui D, Pathak D, Kandiah E, Ruppel KM, Spudich JA, Houdusse A et al (2023) Cryo-EM structure of the folded-back state of human \u03b2-cardiac myosin. Nat Commun 14:3166","journal-title":"Nat Commun"},{"key":"199_CR35","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1006\/jmbi.1998.2522","volume":"286","author":"M Gruen","year":"1999","unstructured":"Gruen M, Gautel M (1999) Mutations in beta-myosin S2 that cause familial hypertrophic cardiomyopathy (FHC) abolish the interaction with the regulatory domain of myosin-binding protein-C. J Mol Biol 286:933\u2013949","journal-title":"J Mol Biol"},{"key":"199_CR36","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/S0014-5793(99)00727-9","volume":"453","author":"M Gruen","year":"1999","unstructured":"Gruen M, Prinz H, Gautel M (1999) cAPK\u2010phosphorylation controls the interaction of the regulatory domain of cardiac myosin binding protein C with myosin\u2010S2 in an on\u2010off fashion. FEBS Lett 453:254\u2013259","journal-title":"FEBS Lett"},{"key":"199_CR37","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1093\/ehjci\/jew005","volume":"17","author":"TF Haland","year":"2016","unstructured":"Haland TF, Almaas VM, Hasselberg NE, Saberniak J, Leren IS, Hopp E, Edvardsen T, Haugaa KH (2016) Strain echocardiography is related to fibrosis and ventricular arrhythmias in hypertrophic cardiomyopathy. Eur Heart J Cardiovasc Imaging 17:613\u2013621","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"199_CR38","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1161\/CIRCRESAHA.110.231670","volume":"108","author":"SP Harris","year":"2011","unstructured":"Harris SP, Lyons RG, Bezold KL (2011) In the thick of it: HCM-causing mutations in myosin binding proteins of the thick filament. Circ Res 108:751\u2013764","journal-title":"Circ Res"},{"key":"199_CR39","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1016\/j.jacc.2021.09.1381","volume":"78","author":"SM Hegde","year":"2021","unstructured":"Hegde SM, Lester SJ, Solomon SD, Michels M, Elliott PM, Nagueh SF, Choudhury L, Zemanek D, Zwas DR, Jacoby D et al (2021) Effect of mavacamten on echocardiographic features in symptomatic patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 78:2518\u20132532","journal-title":"J Am Coll Cardiol"},{"key":"199_CR40","doi-asserted-by":"publisher","first-page":"eabk3273","DOI":"10.1126\/sciadv.abk3273","volume":"7","author":"SM Heissler","year":"2021","unstructured":"Heissler SM, Arora AS, Billington N, Sellers JR, Chinthalapudi K (2021) Cryo-EM structure of the autoinhibited state of myosin-2. Sci Adv 7:eabk3273","journal-title":"Sci Adv"},{"key":"199_CR41","doi-asserted-by":"publisher","first-page":"741","DOI":"10.7326\/M18-3016","volume":"170","author":"SB Heitner","year":"2019","unstructured":"Heitner SB, Jacoby D, Lester SJ, Owens A, Wang A, Zhang D, Lambing J, Lee J, Semigran M, Sehnert AJ (2019) Mavacamten treatment for obstructive hypertrophic cardiomyopathy: a clinical trial. Ann Intern Med 170:741\u2013748","journal-title":"Ann Intern Med"},{"key":"199_CR42","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1161\/CIRCGENETICS.109.862128","volume":"2","author":"CY Ho","year":"2009","unstructured":"Ho CY, Carlsen C, Thune JJ, Havndrup O, Bundgaard H, Farrohi F, Rivero J, Cirino AL, Andersen PS, Christiansen M et al (2009) Echocardiographic strain imaging to assess early and late consequences of sarcomere mutations in hypertrophic cardiomyopathy. Circ Cardiovasc Genet 2:314\u2013321","journal-title":"Circ Cardiovasc Genet"},{"key":"199_CR43","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1161\/01.CIR.0000019070.70491.6D","volume":"105","author":"CY Ho","year":"2002","unstructured":"Ho CY, Sweitzer NK, McDonough B, Maron BJ, Casey SA, Seidman JG, Seidman CE, Solomon SD (2002) Assessment of diastolic function with doppler tissue imaging to predict genotype in preclinical hypertrophic cardiomyopathy. Circulation 105:2992\u20132997","journal-title":"Circulation"},{"key":"199_CR44","doi-asserted-by":"publisher","first-page":"6701","DOI":"10.1073\/pnas.1606950113","volume":"113","author":"JR Homburger","year":"2016","unstructured":"Homburger JR, Green EM, Caleshu C, Sunitha MS, Taylor RE, Ruppel KM, Metpally RPR, Colan SD, Michels M, Day SM et al (2016) Multidimensional structure-function relationships in human \u03b2-cardiac myosin from population-scale genetic variation. Proc Natl Acad Sci USA 113:6701\u20136706","journal-title":"Proc Natl Acad Sci USA"},{"key":"199_CR45","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1016\/j.bpj.2011.02.061","volume":"100","author":"P Hooijman","year":"2011","unstructured":"Hooijman P, Stewart MA, Cooke R (2011) A new state of cardiac myosin with very slow ATP turnover: a potential cardioprotective mechanism in the heart. Biophys J 100:1969\u20131976","journal-title":"Biophys J"},{"key":"199_CR46","doi-asserted-by":"publisher","first-page":"6828","DOI":"10.1073\/pnas.1816480116","volume":"116","author":"AV Inchingolo","year":"2019","unstructured":"Inchingolo AV, Previs SB, Previs MJ, Warshaw DM, Kad NM (2019) Revealing the mechanism of how cardiac myosin-binding protein C N-terminal fragments sensitize thin filaments for myosin binding. Proc Natl Acad Sci USA 116:6828\u20136835","journal-title":"Proc Natl Acad Sci USA"},{"key":"199_CR47","doi-asserted-by":"publisher","first-page":"pgae039","DOI":"10.1093\/pnasnexus\/pgae039","volume":"3","author":"VP Jani","year":"2024","unstructured":"Jani VP, Song T, Gao C, Gong H, Sadayappan S, Kass DA, Irving TC, Ma W (2024) The structural OFF and ON states of myosin can be decoupled from the biochemical super-and disordered-relaxed states. PNAS Nexus 3:pgae039","journal-title":"PNAS Nexus"},{"key":"199_CR48","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.jmb.2011.03.019","volume":"408","author":"HS Jung","year":"2011","unstructured":"Jung HS, Billington N, Thirumurugan K, Salzameda B, Cremo CR, Chalovich JM, Chantler PD, Knight PJ (2011) Role of the tail in the regulated state of myosin 2. J Mol Biol 408:863\u2013878","journal-title":"J Mol Biol"},{"key":"199_CR49","doi-asserted-by":"publisher","first-page":"6022","DOI":"10.1073\/pnas.0707846105","volume":"105","author":"HS Jung","year":"2008","unstructured":"Jung HS, Burgess SA, Billington N, Colegrave M, Patel H, Chalovich JM, Chantler PD, Knight PJ (2008a) Conservation of the regulated structure of folded myosin 2 in species separated by at least 600 million years of independent evolution. Proc Natl Acad Sci USA 105:6022\u20136026","journal-title":"Proc Natl Acad Sci USA"},{"key":"199_CR50","doi-asserted-by":"publisher","first-page":"3234","DOI":"10.1091\/mbc.e08-02-0206","volume":"19","author":"HS Jung","year":"2008","unstructured":"Jung HS, Komatsu S, Ikebe M, Craig R (2008b) Head\u2013head and head\u2013tail interaction: a general mechanism for switching off myosin II activity in cells. Mol Biol Cell 19:3234\u20133242","journal-title":"Mol Biol Cell"},{"key":"199_CR51","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.yjmcc.2015.06.002","volume":"85","author":"T Kampourakis","year":"2015","unstructured":"Kampourakis T, Irving M (2015) Phosphorylation of myosin regulatory light chain controls myosin head conformation in cardiac muscle. J Mol Cell Cardiol 85:199\u2013206","journal-title":"J Mol Cell Cardiol"},{"key":"199_CR52","doi-asserted-by":"publisher","first-page":"18763","DOI":"10.1073\/pnas.1413922112","volume":"111","author":"T Kampourakis","year":"2014","unstructured":"Kampourakis T, Yan Z, Gautel M, Sun Y-B, Irving M (2014) Myosin binding protein-C activates thin filaments and inhibits thick filaments in heart muscle cells. Proc Natl Acad Sci USA 111:18763\u201318768","journal-title":"Proc Natl Acad Sci USA"},{"key":"199_CR53","doi-asserted-by":"publisher","first-page":"258a","DOI":"10.1016\/j.bpj.2022.11.1488","volume":"122","author":"M Kawana","year":"2023","unstructured":"Kawana M, Goluguri RR, Dawood A, Spudich JA, Ruppel K (2023) Molecular characterization of a novel MYH7 mutation Q222H in a patient with severe dilated cardiomyopathy. Biophys J 122:258a","journal-title":"Biophys J"},{"key":"199_CR54","doi-asserted-by":"publisher","first-page":"e1601959","DOI":"10.1126\/sciadv.1601959","volume":"3","author":"M Kawana","year":"2017","unstructured":"Kawana M, Sarkar SS, Sutton S, Ruppel KM, Spudich JA (2017) Biophysical properties of human beta-cardiac myosin with converter mutations that cause hypertrophic cardiomyopathy. Sci Adv 3:e1601959","journal-title":"Sci Adv"},{"key":"199_CR55","doi-asserted-by":"publisher","first-page":"975076","DOI":"10.3389\/fphys.2022.975076","volume":"13","author":"M Kawana","year":"2022","unstructured":"Kawana M, Spudich JA, Ruppel KM (2022) Hypertrophic cardiomyopathy: mutations to mechanisms to therapies. Front Physiol 13:975076","journal-title":"Front Physiol"},{"key":"199_CR56","first-page":"E1991","volume":"115","author":"KH Lee","year":"2018","unstructured":"Lee KH, Sulbar\u00e1n G, Yang S, Mun JY, Alamo L, Pinto A, Sato O, Ikebe M, Liu X, Korn ED et al (2018) Interacting-heads motif has been conserved as a mechanism of myosin II inhibition since before the origin of animals. Proc Natl Acad Sci USA 115:E1991\u2013E2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"199_CR57","doi-asserted-by":"publisher","first-page":"e2318413121","DOI":"10.1073\/pnas.2318413121","volume":"121","author":"S Lee","year":"2024","unstructured":"Lee S, Vander Roest AS, Blair CA, Kao K, Bremner SB, Childers MC, Pathak D, Heinrich P, Lee D, Chirikian O (2024) Incomplete-penetrant hypertrophic cardiomyopathy MYH7 G256E mutation causes hypercontractility and elevated mitochondrial respiration. Proc Natl Acad Sci USA 121:e2318413121","journal-title":"Proc Natl Acad Sci USA"},{"key":"199_CR58","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41569-022-00682-0","volume":"19","author":"SJ Lehman","year":"2022","unstructured":"Lehman SJ, Crocini C, Leinwand LA (2022) Targeting the sarcomere in inherited cardiomyopathies. Nat Rev Cardiol 19:353\u2013363","journal-title":"Nat Rev Cardiol"},{"key":"199_CR59","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/S0006-3495(96)79293-7","volume":"71","author":"RJ Levine","year":"1996","unstructured":"Levine RJ, Kensler RW, Yang Z, Stull JT, Sweeney HL (1996) Myosin light chain phosphorylation affects the structure of rabbit skeletal muscle thick filaments. Biophys J 71:898\u2013907","journal-title":"Biophys J"},{"key":"199_CR60","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/nature04719","volume":"442","author":"J Liu","year":"2006","unstructured":"Liu J, Taylor DW, Krementsova EB, Trybus KM, Taylor KA (2006) Three-dimensional structure of the myosin V inhibited state by cryoelectron tomography. Nature 442:208\u2013211","journal-title":"Nature"},{"key":"199_CR61","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/S0022-2836(03)00516-3","volume":"329","author":"J Liu","year":"2003","unstructured":"Liu J, Wendt T, Taylor D, Taylor K (2003) Refined model of the 10\u2009S conformation of smooth muscle myosin by cryo-electron microscopy 3D image reconstruction. J Mol Biol 329:963\u2013972","journal-title":"J Mol Biol"},{"key":"199_CR62","doi-asserted-by":"publisher","first-page":"13185","DOI":"10.1074\/jbc.M800757200","volume":"283","author":"L Liu","year":"2008","unstructured":"Liu L, Srikakulam R, Winkelmann DA (2008) Unc45 activates Hsp90-dependent folding of the myosin motor domain. J Biol Chem 283:13185\u201393","journal-title":"J Biol Chem"},{"key":"199_CR63","doi-asserted-by":"crossref","first-page":"120S","DOI":"10.1016\/S0006-3495(95)80237-7","volume":"68","author":"S Lowey","year":"1995","unstructured":"Lowey S, Trybus KM (1995) Role of skeletal and smooth muscle myosin light chains. Biophys J 68:120S\u2013126S","journal-title":"Biophys J"},{"key":"199_CR64","doi-asserted-by":"publisher","first-page":"16403","DOI":"10.1074\/jbc.R109.025551","volume":"285","author":"S Lowey","year":"2010","unstructured":"Lowey S, Trybus KM (2010) Common structural motifs for the regulation of divergent class II myosins. J Biol Chem 285:16403\u201316407","journal-title":"J Biol Chem"},{"key":"199_CR65","doi-asserted-by":"publisher","first-page":"e2207615120","DOI":"10.1073\/pnas.2207615120","volume":"120","author":"W Ma","year":"2023","unstructured":"Ma W, McMillen TS, Childers MC, Gong H, Regnier M, Irving T (2023) Structural OFF\/ON transitions of myosin in relaxed porcine myocardium predict calcium-activated force. Proc Natl Acad Sci USA 120:e2207615120","journal-title":"Proc Natl Acad Sci USA"},{"key":"199_CR66","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jacc.2022.10.020","volume":"81","author":"MS Maron","year":"2023","unstructured":"Maron MS, Masri A, Choudhury L, Olivotto I, Saberi S, Wang A, Garcia-Pavia P, Lakdawala NK, Nagueh SF, Rader F et al (2023) Phase 2 study of aficamten in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 81:34\u201345","journal-title":"J Am Coll Cardiol"},{"key":"199_CR67","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1161\/CIRCRESAHA.109.202440","volume":"105","author":"S Marston","year":"2009","unstructured":"Marston S, Copeland O, Jacques A, Livesey K, Tsang V, McKenna WJ, Jalilzadeh S, Carballo S, Redwood C, Watkins H (2009) Evidence from human myectomy samples that MYBPC3 mutations cause hypertrophic cardiomyopathy through haploinsufficiency. Circ Res 105:219\u2013222","journal-title":"Circ Res"},{"key":"199_CR68","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s12551-014-0151-5","volume":"7","author":"JW McNamara","year":"2015","unstructured":"McNamara JW, Li A, Dos Remedios CG, Cooke R (2015) The role of super-relaxed myosin in skeletal and cardiac muscle. Biophys Rev 7:5\u201314","journal-title":"Biophys Rev"},{"key":"199_CR69","doi-asserted-by":"publisher","first-page":"e0180064","DOI":"10.1371\/journal.pone.0180064","volume":"12","author":"JW McNamara","year":"2017","unstructured":"McNamara JW, Li A, Lal S, Bos JM, Harris SP, van der Velden J, Ackerman MJ, Cooke R, Dos Remedios CG (2017) MYBPC3 mutations are associated with a reduced super-relaxed state in patients with hypertrophic cardiomyopathy. PLoS ONE 12:e0180064","journal-title":"PLoS ONE"},{"key":"199_CR70","doi-asserted-by":"publisher","first-page":"105565","DOI":"10.1016\/j.jbc.2023.105565","volume":"300","author":"S Mohran","year":"2024","unstructured":"Mohran S, Kooiker K, Mahoney-Schaefer M, Mandrycky C, Kao K, Tu A-Y, Freeman J, Moussavi-Harami F, Geeves M, Regnier M (2024) The biochemically defined super relaxed state of myosin\u2014a paradox. J Biol Chem 300:105565","journal-title":"J Biol Chem"},{"key":"199_CR71","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1161\/CIRCRESAHA.110.223842","volume":"111","author":"JR Moore","year":"2012","unstructured":"Moore JR, Leinwand L, Warshaw DM (2012) Understanding cardiomyopathy phenotypes based on the functional impact of mutations in the myosin motor. Circ Res 111:375\u2013385","journal-title":"Circ Res"},{"key":"199_CR72","doi-asserted-by":"publisher","first-page":"e76805","DOI":"10.7554\/eLife.76805","volume":"11","author":"MM Morck","year":"2022","unstructured":"Morck MM, Bhowmik D, Pathak D, Dawood A, Spudich J, Ruppel KM (2022) Hypertrophic cardiomyopathy mutations in the pliant and light chain-binding regions of the lever arm of human \u03b2-cardiac myosin have divergent effects on myosin function. Elife 11:e76805","journal-title":"Elife"},{"key":"199_CR73","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1161\/CIRCRESAHA.116.300561","volume":"116","author":"RL Moss","year":"2015","unstructured":"Moss RL, Fitzsimons DP, Ralphe JC (2015) Cardiac MyBP-C regulates the rate and force of contraction in mammalian myocardium. Circ Res 116:183\u2013192","journal-title":"Circ Res"},{"key":"199_CR74","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1073\/pnas.1316001111","volume":"111","author":"JY Mun","year":"2014","unstructured":"Mun JY, Previs MJ, Yu HY, Gulick J, Tobacman LS, Previs SB, Robbins J, Warshaw DM, Craig R (2014) Myosin-binding protein C displaces tropomyosin to activate cardiac thin filaments and governs their speed by an independent mechanism. Proc Natl Acad Sci USA 111:2170\u20132175","journal-title":"Proc Natl Acad Sci USA"},{"key":"199_CR75","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.jmb.2011.06.051","volume":"411","author":"N Naber","year":"2011","unstructured":"Naber N, Cooke R, Pate E (2011) Slow myosin ATP turnover in the super-relaxed state in tarantula muscle. J Mol Biol 411:943\u2013950","journal-title":"J Mol Biol"},{"key":"199_CR76","doi-asserted-by":"publisher","first-page":"eabo7622","DOI":"10.1126\/sciadv.abo7622","volume":"9","author":"S Nag","year":"2023","unstructured":"Nag S, Gollapudi SK, Del Rio CL, Spudich JA, McDowell R (2023) Mavacamten, a precision medicine for hypertrophic cardiomyopathy: from a motor protein to patients. Sci Adv 9:eabo7622","journal-title":"Sci Adv"},{"key":"199_CR77","doi-asserted-by":"publisher","first-page":"e1500511","DOI":"10.1126\/sciadv.1500511","volume":"1","author":"S Nag","year":"2015","unstructured":"Nag S, Sommese RF, Ujfalusi Z, Combs A, Langer S, Sutton S, Leinwand LA, Geeves MA, Ruppel KM, Spudich JA (2015) Contractility parameters of human beta-cardiac myosin with the hypertrophic cardiomyopathy mutation R403Q show loss of motor function. Sci Adv 1:e1500511","journal-title":"Sci Adv"},{"key":"199_CR78","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nsmb.3408","volume":"24","author":"S Nag","year":"2017","unstructured":"Nag S, Trivedi DV, Sarkar SS, Adhikari AS, Sunitha MS, Sutton S, Ruppel KM, Spudich JA (2017) The myosin mesa and the basis of hypercontractility caused by hypertrophic cardiomyopathy mutations. Nat Struct Mol Biol 24:525\u2013533","journal-title":"Nat Struct Mol Biol"},{"key":"199_CR79","doi-asserted-by":"publisher","unstructured":"Nandwani N, Bhowmik D, Childers MC, Goluguri RR, Dawood A, Regnier M, Spudich JA, Ruppel KM (2024) Hypertrophic cardiomyopathy mutations Y115H and E497D disrupt the folded-back state of human \u03b2-cardiac myosin allosterically. Preprint at https:\/\/doi.org\/10.1101\/2024.02.29.582851","DOI":"10.1101\/2024.02.29.582851"},{"key":"199_CR80","doi-asserted-by":"publisher","first-page":"e202213276","DOI":"10.1085\/jgp.202213276","volume":"155","author":"S Nelson","year":"2023","unstructured":"Nelson S, Beck-Previs S, Sadayappan S, Tong C, Warshaw DM (2023) Myosin-binding protein C stabilizes, but is not the sole determinant of SRX myosin in cardiac muscle. J Gen Physiol 155:e202213276","journal-title":"J Gen Physiol"},{"key":"199_CR81","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1016\/j.biocel.2006.12.008","volume":"39","author":"CE Oakley","year":"2007","unstructured":"Oakley CE, Chamoun J, Brown LJ, Hambly BD (2007) Myosin binding protein\u2014C: enigmatic regulator of cardiac contraction. Int J Biochem Cell Biol 39:2161\u20132166","journal-title":"Int J Biochem Cell Biol"},{"key":"199_CR82","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1006\/jmbi.1996.0096","volume":"256","author":"G Offer","year":"1996","unstructured":"Offer G, Knight P (1996) The structure of the head-tail junction of the myosin molecule. J Mol Biol 256:407\u2013416","journal-title":"J Mol Biol"},{"key":"199_CR83","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/BF01745112","volume":"12","author":"R Padr\u00f3n","year":"1991","unstructured":"Padr\u00f3n R, Pant\u00e9 N, Sosa H, Kendrick-Jones J (1991) X-ray diffraction study of the structural changes accompanying phosphorylation of tarantula muscle. J Muscle Res Cell Motil 12:235\u2013241","journal-title":"J Muscle Res Cell Motil"},{"key":"199_CR84","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s10974-012-9291-z","volume":"33","author":"M Pfuhl","year":"2012","unstructured":"Pfuhl M, Gautel M (2012) Structure, interactions and function of the N-terminus of cardiac myosin binding protein C (MyBP-C): who does what, with what, and to whom? J Muscle Res Cell Motil 33:83\u201394","journal-title":"J Muscle Res Cell Motil"},{"key":"199_CR85","doi-asserted-by":"publisher","first-page":"e202213087","DOI":"10.1085\/jgp.202213087","volume":"155","author":"M Pilagov","year":"2022","unstructured":"Pilagov M, Heling LWHJ, Walklate J, Geeves MA, Kad NM (2022) Single-molecule imaging reveals how mavacamten and PKA modulate ATP turnover in skeletal muscle myofibrils. J Gen Physiol 155:e202213087","journal-title":"J Gen Physiol"},{"key":"199_CR86","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00424-013-1433-7","volume":"466","author":"MJ Previs","year":"2014","unstructured":"Previs MJ, Michalek AJ, Warshaw DM (2014) Molecular modulation of actomyosin function by cardiac myosin-binding protein C. Pflug Arch 466:439\u2013444","journal-title":"Pflug Arch"},{"key":"199_CR87","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1126\/science.1223602","volume":"337","author":"MJ Previs","year":"2012","unstructured":"Previs MJ, Previs SB, Gulick J, Robbins J, Warshaw DM (2012) Molecular mechanics of cardiac myosin-binding protein C in native thick filaments. Science 337:1215\u20131218","journal-title":"Science"},{"key":"199_CR88","doi-asserted-by":"publisher","first-page":"e2024151118","DOI":"10.1073\/pnas.2024151118","volume":"118","author":"H Rahmani","year":"2021","unstructured":"Rahmani H, Ma W, Hu Z, Daneshparvar N, Taylor DW, McCammon JA, Irving TC, Edwards RJ, Taylor KA (2021) The myosin II coiled-coil domain atomic structure in its native environment. Proc Natl Acad Sci USA 118:e2024151118","journal-title":"Proc Natl Acad Sci USA"},{"key":"199_CR89","doi-asserted-by":"publisher","first-page":"e202012726","DOI":"10.1085\/jgp.202012726","volume":"153","author":"S Rahmanseresht","year":"2021","unstructured":"Rahmanseresht S, Lee KH, O\u2019Leary TS, McNamara JW, Sadayappan S, Robbins J, Warshaw DM, Craig R, Previs MJ (2021) The N terminus of myosin-binding protein C extends toward actin filaments in intact cardiac muscle. J Gen Physiol 153:e202012726","journal-title":"J Gen Physiol"},{"key":"199_CR90","doi-asserted-by":"publisher","first-page":"e77415","DOI":"10.7554\/eLife.77415","volume":"11","author":"DV Rasicci","year":"2022","unstructured":"Rasicci DV, Tiwari P, Bodt SML, Desetty R, Sadler FR, Sivaramakrishnan S, Craig R, Yengo CM (2022) Dilated cardiomyopathy mutation E525K in human beta-cardiac myosin stabilizes the interacting-heads motif and super-relaxed state of myosin. Elife 11:e77415","journal-title":"Elife"},{"key":"199_CR91","doi-asserted-by":"publisher","first-page":"12650","DOI":"10.1074\/jbc.M110.156646","volume":"286","author":"J Ratti","year":"2011","unstructured":"Ratti J, Rostkova E, Gautel M, Pfuhl M (2011) Structure and interactions of myosin-binding protein C domain C0: cardiac-specific regulation of myosin at its neck? J Biol Chem 286:12650\u201312658","journal-title":"J Biol Chem"},{"key":"199_CR92","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1073\/pnas.0913527107","volume":"107","author":"DI Resnicow","year":"2010","unstructured":"Resnicow DI, Deacon JC, Warrick HM, Spudich JA, Leinwand LA (2010) Functional diversity among a family of human skeletal muscle myosin motors. Proc Natl Acad Sci USA 107:1053\u20131058","journal-title":"Proc Natl Acad Sci USA"},{"key":"199_CR93","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06191-4","volume":"9","author":"J Robert-Paganin","year":"2018","unstructured":"Robert-Paganin J, Auguin D, Houdusse A (2018) Hypertrophic cardiomyopathy disease results from disparate impairments of cardiac myosin function and auto-inhibition. Nat Commun 9:4019","journal-title":"Nat Commun"},{"key":"199_CR94","doi-asserted-by":"publisher","first-page":"E7486","DOI":"10.1073\/pnas.1720342115","volume":"115","author":"JA Rohde","year":"2018","unstructured":"Rohde JA, Roopnarine O, Thomas DD, Muretta JM (2018) Mavacamten stabilizes an autoinhibited state of two-headed cardiac myosin. Proc Natl Acad Sci USA 115:E7486\u2013E7494","journal-title":"Proc Natl Acad Sci USA"},{"key":"199_CR95","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1161\/CIRCULATIONAHA.120.052359","volume":"143","author":"S Saberi","year":"2021","unstructured":"Saberi S, Cardim N, Yamani M, Schulz-Menger J, Li W, Florea V, Sehnert AJ, Kwong RY, Jerosch-Herold M, Masri A et al (2021) Mavacamten favorably impacts cardiac structure in obstructive hypertrophic cardiomyopathy. Circulation 143:606\u2013608","journal-title":"Circulation"},{"key":"199_CR96","doi-asserted-by":"publisher","first-page":"eaax0069","DOI":"10.1126\/sciadv.aax0069","volume":"6","author":"SS Sarkar","year":"2020","unstructured":"Sarkar SS, Trivedi DV, Morck MM, Adhikari AS, Pasha SN, Ruppel KM, Spudich JA (2020) The hypertrophic cardiomyopathy mutations R403Q and R663H increase the number of myosin heads available to interact with actin. Sci Adv 6:eaax0069","journal-title":"Sci Adv"},{"key":"199_CR97","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41586-020-2990-5","volume":"588","author":"CA Scarff","year":"2020","unstructured":"Scarff CA, Carrington G, Casas-Mao D, Chalovich JM, Knight PJ, Ranson NA, Peckham M (2020) Structure of the shutdown state of myosin-2. Nature 588:515\u2013520","journal-title":"Nature"},{"key":"199_CR98","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.abb.2011.02.013","volume":"510","author":"SB Scruggs","year":"2011","unstructured":"Scruggs SB, Solaro RJ (2011) The significance of regulatory light chain phosphorylation in cardiac physiology. Arch Biochem Biophys 510:129\u2013134","journal-title":"Arch Biochem Biophys"},{"key":"199_CR99","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/S0092-8674(01)00242-2","volume":"104","author":"JG Seidman","year":"2001","unstructured":"Seidman JG, Seidman C (2001) The genetic basis for cardiomyopathy. Cell 104:557\u2013567","journal-title":"Cell"},{"key":"199_CR100","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.jacc.2015.01.019","volume":"65","author":"C Semsarian","year":"2015","unstructured":"Semsarian C, Ingles J, Maron MS, Maron BJ (2015) New perspectives on the prevalence of hypertrophic cardiomyopathy. J Am Coll Cardiol 65:1249\u20131254","journal-title":"J Am Coll Cardiol"},{"key":"199_CR101","doi-asserted-by":"publisher","unstructured":"Sen-Mart\u00edn L, Fern\u00e1ndez-Trasancos \u00c1, L\u00f3pez-Unzu M\u00c1, Pathak D, Ferrarini A, Labrador-Cantarero V, S\u00e1nchez-Ortiz D, Pricolo MR, Vicente N, Vel\u00e1zquez-Carreras D et al (2024) Broad therapeutic benefit of myosin inhibition in hypertrophic cardiomyopathy. Preprint at https:\/\/doi.org\/10.1101\/2024.03.22.584986","DOI":"10.1101\/2024.03.22.584986"},{"key":"199_CR102","doi-asserted-by":"publisher","first-page":"100836","DOI":"10.1016\/j.jbc.2021.100836","volume":"297","author":"RR Singh","year":"2021","unstructured":"Singh RR, McNamara JW, Sadayappan S (2021) Mutations in myosin S2 alter cardiac myosin-binding protein-C interaction in hypertrophic cardiomyopathy in a phosphorylation-dependent manner. J Biol Chem 297:100836","journal-title":"J Biol Chem"},{"key":"199_CR103","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1007\/s12265-009-9129-2","volume":"2","author":"S Sivaramakrishnan","year":"2009","unstructured":"Sivaramakrishnan S, Ashley E, Leinwand L, Spudich JA (2009) Insights into human \u03b2-cardiac myosin function from single molecule and single cell studies. J Cardiovasc Transl Res 2:426\u2013440","journal-title":"J Cardiovasc Transl Res"},{"key":"199_CR104","doi-asserted-by":"publisher","first-page":"12607","DOI":"10.1073\/pnas.1309493110","volume":"110","author":"RF Sommese","year":"2013","unstructured":"Sommese RF, Sung J, Nag S, Sutton S, Deacon JC, Choe E, Leinwand LA, Ruppel K, Spudich JA (2013) Molecular consequences of the R453C hypertrophic cardiomyopathy mutation on human \u03b2-cardiac myosin motor function. Proc Natl Acad Sci USA 110:12607\u201312612","journal-title":"Proc Natl Acad Sci USA"},{"key":"199_CR105","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1042\/BST20140324","volume":"43","author":"JA Spudich","year":"2015","unstructured":"Spudich JA (2015) The myosin mesa and a possible unifying hypothesis for the molecular basis of human hypertrophic cardiomyopathy. Biochem Soc Trans 43:64\u201372","journal-title":"Biochem Soc Trans"},{"key":"199_CR106","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s00424-019-02259-2","volume":"471","author":"JA Spudich","year":"2019","unstructured":"Spudich JA (2019) Three perspectives on the molecular basis of hypercontractility caused by hypertrophic cardiomyopathy mutations. Pflug Arch 471:701\u2013717","journal-title":"Pflug Arch"},{"key":"199_CR107","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1242\/jeb.125930","volume":"219","author":"JA Spudich","year":"2016","unstructured":"Spudich JA, Aksel T, Bartholomew SR, Nag S, Kawana M, Yu EC, Sarkar SS, Sung J, Sommese RF, Sutton S et al (2016) Effects of hypertrophic and dilated cardiomyopathy mutations on power output by human beta-cardiac myosin. J Exp Biol 219:161\u2013167","journal-title":"J Exp Biol"},{"key":"199_CR108","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1242\/jcs.00899","volume":"117","author":"R Srikakulam","year":"2004","unstructured":"Srikakulam R, Winkelmann DA (2004) Chaperone-mediated folding and assembly of myosin in striated muscle. J Cell Sci 117:641\u201352","journal-title":"J Cell Sci"},{"key":"199_CR109","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1073\/pnas.0909468107","volume":"107","author":"MA Stewart","year":"2010","unstructured":"Stewart MA, Franks-Skiba K, Chen S, Cooke R (2010) Myosin ATP turnover rate is a mechanism involved in thermogenesis in resting skeletal muscle fibers. Proc Natl Acad Sci USA 107:430\u20135","journal-title":"Proc Natl Acad Sci USA"},{"key":"199_CR110","doi-asserted-by":"publisher","first-page":"E5660","DOI":"10.1073\/pnas.1513439112","volume":"112","author":"G Sulbar\u00e1n","year":"2015","unstructured":"Sulbar\u00e1n G, Alamo L, Pinto A, M\u00e1rquez G, M\u00e9ndez F, Padr\u00f3n R, Craig R (2015) An invertebrate smooth muscle with striated muscle myosin filaments. Proc Natl Acad Sci USA 112:E5660\u2013E5668","journal-title":"Proc Natl Acad Sci USA"},{"key":"199_CR111","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.jmb.2004.10.084","volume":"345","author":"F Tama","year":"2005","unstructured":"Tama F, Feig M, Liu J, Brooks CL, Taylor KA (2005) The requirement for mechanical coupling between head and S2 domains in smooth muscle myosin ATPase regulation and its implications for dimeric motor function. J Mol Biol 345:837\u2013854","journal-title":"J Mol Biol"},{"key":"199_CR112","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1038\/s41586-023-06690-5","volume":"623","author":"D Tamborrini","year":"2023","unstructured":"Tamborrini D, Wang Z, Wagner T, Tacke S, Stabrin M, Grange M, Kho AL, Rees M, Bennett P, Gautel M et al (2023) Structure of the native myosin filament in the relaxed cardiac sarcomere. Nature 623:863\u2013871","journal-title":"Nature"},{"key":"199_CR113","doi-asserted-by":"publisher","first-page":"13446","DOI":"10.1074\/jbc.M113.455444","volume":"288","author":"C Toepfer","year":"2013","unstructured":"Toepfer C, Caorsi V, Kampourakis T, Sikkel MB, West TG, Leung M-C, Al-Saud SA, MacLeod KT, Lyon AR, Marston SB et al (2013) Myosin regulatory light chain (RLC) phosphorylation change as a modulator of cardiac muscle contraction in disease. J Biol Chem 288:13446\u201313454","journal-title":"J Biol Chem"},{"key":"199_CR114","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1161\/CIRCULATIONAHA.119.042339","volume":"141","author":"CN Toepfer","year":"2020","unstructured":"Toepfer CN, Garfinkel AC, Venturini G, Wakimoto H, Repetti G, Alamo L, Sharma A, Agarwal R, Ewoldt JF, Cloonan P et al (2020) Myosin sequestration regulates sarcomere function, cardiomyocyte energetics, and metabolism, informing the pathogenesis of hypertrophic cardiomyopathy. Circulation 141:828\u2013842","journal-title":"Circulation"},{"key":"199_CR115","doi-asserted-by":"publisher","first-page":"eaat1199","DOI":"10.1126\/scitranslmed.aat1199","volume":"11","author":"CN Toepfer","year":"2019","unstructured":"Toepfer CN, Wakimoto H, Garfinkel AC, McDonough B, Liao D, Jiang J, Tai AC, Gorham JM, Lunde IG, Lun M (2019) Hypertrophic cardiomyopathy mutations in MYBPC3 dysregulate myosin. Sci Transl Med 11:eaat1199","journal-title":"Sci Transl Med"},{"key":"199_CR116","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s12551-017-0274-6","volume":"10","author":"DV Trivedi","year":"2018","unstructured":"Trivedi DV, Adhikari AS, Sarkar SS, Ruppel KM, Spudich JA (2018) Hypertrophic cardiomyopathy and the myosin mesa: viewing an old disease in a new light. Biophys Rev 10:27\u201348","journal-title":"Biophys Rev"},{"key":"199_CR117","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1073\/pnas.94.1.48","volume":"94","author":"KM Trybus","year":"1997","unstructured":"Trybus KM, Freyzon Y, Faust LZ, Sweeney HL (1997) Spare the rod, spoil the regulation: necessity for a myosin rod. Proc Natl Acad Sci USA 94:48\u201352","journal-title":"Proc Natl Acad Sci USA"},{"key":"199_CR118","doi-asserted-by":"publisher","first-page":"6151","DOI":"10.1073\/pnas.79.20.6151","volume":"79","author":"KM Trybus","year":"1982","unstructured":"Trybus KM, Huiatt TW, Lowey S (1982) A bent monomeric conformation of myosin from smooth muscle. Proc Natl Acad Sci USA 79:6151\u20136155","journal-title":"Proc Natl Acad Sci USA"},{"key":"199_CR119","doi-asserted-by":"publisher","first-page":"8564","DOI":"10.1016\/S0021-9258(17)39767-3","volume":"259","author":"KM Trybus","year":"1984","unstructured":"Trybus KM, Lowey S (1984) Conformational states of smooth muscle myosin. Effects of light chain phosphorylation and ionic strength. J Biol Chem 259:8564\u201371","journal-title":"J Biol Chem"},{"key":"199_CR120","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/0022-2836(90)90287-V","volume":"214","author":"TQP Uyeda","year":"1990","unstructured":"Uyeda TQP, Kron SJ, Spudich JA (1990) Myosin step size: estimation from slow sliding movement of actin over low densities of heavy meromyosin. J Mol Biol 214:699\u2013710","journal-title":"J Mol Biol"},{"key":"199_CR121","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1161\/CIRCULATIONAHA.108.838672","volume":"119","author":"SJ van Dijk","year":"2009","unstructured":"van Dijk SJ, Dooijes D, dos Remedios C, Michels M, Lamers JMJ, Winegrad S, Schlossarek S, Carrier L, ten Cate FJ, Stienen GJM et al (2009) Cardiac myosin-binding protein C mutations and hypertrophic cardiomyopathy: haploinsufficiency, deranged phosphorylation, and cardiomyocyte dysfunction. Circulation 119:1473\u201383","journal-title":"Circulation"},{"key":"199_CR122","doi-asserted-by":"crossref","unstructured":"Vandenboom R (2016) Modulation of skeletal muscle contraction by myosin phosphorylation. Compr Physiol 7:171\u2013212","DOI":"10.1002\/cphy.c150044"},{"key":"199_CR123","doi-asserted-by":"publisher","first-page":"e2025030118","DOI":"10.1073\/pnas.2025030118","volume":"118","author":"AS Vander Roest","year":"2021","unstructured":"Vander Roest AS, Liu C, Morck MM, Kooiker KB, Jung G, Song D, Dawood A, Jhingran A, Pardon G, Ranjbarvaziri S (2021) Hypertrophic cardiomyopathy \u03b2-cardiac myosin mutation (P710R) leads to hypercontractility by disrupting super relaxed state. Proc Natl Acad Sci USA 118:e2025030118","journal-title":"Proc Natl Acad Sci USA"},{"key":"199_CR124","doi-asserted-by":"publisher","first-page":"17451","DOI":"10.1074\/jbc.RA119.010563","volume":"294","author":"CD Vera","year":"2019","unstructured":"Vera CD, Johnson CA, Walklate J, Adhikari A, Svicevic M, Mijailovich SM, Combs AC, Langer SJ, Ruppel KM, Spudich JA et al (2019) Myosin motor domains carrying mutations implicated in early or late onset hypertrophic cardiomyopathy have similar properties. J Biol Chem 294:17451\u201317462","journal-title":"J Biol Chem"},{"key":"199_CR125","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","volume":"141","author":"SS Virani","year":"2020","unstructured":"Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Delling FN (2020) Heart disease and stroke statistics\u20142020 update: a report from the American Heart Association. Circulation 141:e139\u2013e596","journal-title":"Circulation"},{"key":"199_CR126","doi-asserted-by":"publisher","first-page":"101640","DOI":"10.1016\/j.jbc.2022.101640","volume":"298","author":"J Walklate","year":"2022","unstructured":"Walklate J, Kao K, Regnier M, Geeves MA (2022) Exploring the super-relaxed state of myosin in myofibrils from fast-twitch, slow-twitch, and cardiac muscle. J Biol Chem 298:101640","journal-title":"J Biol Chem"},{"key":"199_CR127","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1002\/ejhf.144","volume":"16","author":"J Wang","year":"2014","unstructured":"Wang J, Wang Y, Zou Y, Sun K, Wang Z, Ding H, Yuan J, Wei W, Hou Q, Wang H et al (2014) Malignant effects of multiple rare variants in sarcomere genes on the prognosis of patients with hypertrophic cardiomyopathy. Eur J Heart Fail 16:950\u2013957","journal-title":"Eur J Heart Fail"},{"key":"199_CR128","doi-asserted-by":"publisher","first-page":"4227","DOI":"10.1242\/jcs.00709","volume":"116","author":"Q Wang","year":"2003","unstructured":"Wang Q, Moncman CL, Winkelmann DA (2003) Mutations in the motor domain modulate myosin activity and myofibril organization. J Cell Sci 116:4227\u20134238","journal-title":"J Cell Sci"},{"key":"199_CR129","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1083\/jcb.147.7.1385","volume":"147","author":"T Wendt","year":"1999","unstructured":"Wendt T, Taylor D, Messier T, Trybus KM, Taylor KA (1999) Visualization of head\u2013head interactions in the inhibited state of smooth muscle myosin. J Cell Biol 147:1385\u20131390","journal-title":"J Cell Biol"},{"key":"199_CR130","doi-asserted-by":"publisher","first-page":"4361","DOI":"10.1073\/pnas.071051098","volume":"98","author":"T Wendt","year":"2001","unstructured":"Wendt T, Taylor D, Trybus KM, Taylor K (2001) Three-dimensional image reconstruction of dephosphorylated smooth muscle heavy meromyosin reveals asymmetry in the interaction between myosin heads and placement of subfragment 2. Proc Natl Acad Sci USA 98:4361\u20134366","journal-title":"Proc Natl Acad Sci USA"},{"key":"199_CR131","doi-asserted-by":"publisher","first-page":"8561","DOI":"10.1073\/pnas.1218462110","volume":"110","author":"JL Woodhead","year":"2013","unstructured":"Woodhead JL, Zhao F-Q, Craig R (2013) Structural basis of the relaxed state of a Ca2+-regulated myosin filament and its evolutionary implications. Proc Natl Acad Sci USA 110:8561\u20138566","journal-title":"Proc Natl Acad Sci USA"},{"key":"199_CR132","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1038\/nature03920","volume":"436","author":"JL Woodhead","year":"2005","unstructured":"Woodhead JL, Zhao FQ, Craig R, Egelman EH, Alamo L, Padr\u00f3n R (2005) Atomic model of a myosin filament in the relaxed state. Nature 436:1195\u20131199","journal-title":"Nature"},{"key":"199_CR133","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/s41586-020-3007-0","volume":"588","author":"S Yang","year":"2020","unstructured":"Yang S, Tiwari P, Lee KH, Sato O, Ikebe M, Padr\u00f3n R, Craig R (2020) Cryo-EM structure of the inhibited (10\u2009S) form of myosin II. Nature 588:521\u2013525","journal-title":"Nature"},{"key":"199_CR134","doi-asserted-by":"publisher","first-page":"e2110328119","DOI":"10.1073\/pnas.2110328119","volume":"119","author":"C-C Yuan","year":"2022","unstructured":"Yuan C-C, Kazmierczak K, Liang J, Ma W, Irving TC, Szczesna-Cordary D (2022) Molecular basis of force-pCa relation in MYL2 cardiomyopathy mice: Role of the super-relaxed state of myosin. Proc Natl Acad Sci USA 119:e2110328119","journal-title":"Proc Natl Acad Sci USA"},{"key":"199_CR135","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.jmb.2008.10.038","volume":"385","author":"F-Q Zhao","year":"2009","unstructured":"Zhao F-Q, Craig R, Woodhead JL (2009) Head\u2013head interaction characterizes the relaxed state of Limulus muscle myosin filaments. J Mol Biol 385:423\u2013431","journal-title":"J Mol Biol"},{"key":"199_CR136","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1073\/pnas.0708912105","volume":"105","author":"ME Zoghbi","year":"2008","unstructured":"Zoghbi ME, Woodhead JL, Moss RL, Craig R (2008) Three-dimensional structure of vertebrate cardiac muscle myosin filaments. Proc Natl Acad Sci USA 105:2386\u20132390","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["The EMBO Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44318-024-00199-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44318-024-00199-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44318-024-00199-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:38:29Z","timestamp":1779237509000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44318-024-00199-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,27]]},"references-count":136,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2024,10,1]]}},"alternative-id":["199"],"URL":"https:\/\/doi.org\/10.1038\/s44318-024-00199-x","relation":{},"ISSN":["1460-2075"],"issn-type":[{"value":"1460-2075","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,27]]},"assertion":[{"value":"23 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"JAS is cofounder and on the Scientific Advisory Board of Cytokinetics, Inc., a company developing small molecule therapeutics for treatment of hypertrophic cardiomyopathy. JAS is cofounder and Executive Chairman, and KMR is cofounder & Research and Clinical Advisor, of Kainomyx, Inc., a company developing small molecule therapeutics targeting myosins in parasites. AH receives research funding from Cytokinetics and consults for Kainomyx.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}]}}